New Leaf Venture Partners, L.L.C. - PASSAGE BIO INC ownership

PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 55 filers reported holding PASSAGE BIO INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
New Leaf Venture Partners, L.L.C. ownership history of PASSAGE BIO INC
ValueSharesWeighting
Q3 2023$1,648,629
-29.8%
2,497,9220.0%2.12%
+5.0%
Q2 2023$2,348,047
-2.1%
2,497,9220.0%2.02%
+1.8%
Q1 2023$2,398,005
-30.4%
2,497,9220.0%1.98%
-20.6%
Q4 2022$3,447,132
+10.4%
2,497,9220.0%2.50%
+34.8%
Q3 2022$3,122,000
-47.0%
2,497,9220.0%1.85%
-51.5%
Q2 2022$5,895,000
-23.9%
2,497,9220.0%3.82%
+0.1%
Q1 2022$7,744,000
-51.2%
2,497,9220.0%3.82%
-33.6%
Q4 2021$15,862,000
-36.2%
2,497,9220.0%5.75%
-19.9%
Q3 2021$24,879,000
+1591.3%
2,497,9220.0%7.18%
+1798.4%
Q2 2021$1,471,000
-96.6%
2,497,9220.0%0.38%
-96.3%
Q1 2021$43,664,000
-31.6%
2,497,9220.0%10.16%
-31.1%
Q4 2020$63,872,000
+95.0%
2,497,9220.0%14.76%
+11.8%
Q3 2020$32,748,000
-52.0%
2,497,9220.0%13.20%
-32.6%
Q2 2020$68,268,000
+73.5%
2,497,9220.0%19.59%
+66.4%
Q1 2020$39,342,0002,497,92211.77%
Other shareholders
PASSAGE BIO INC shareholders Q2 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,959,769$6,200,00010.57%
Lynx1 Capital Management LP 2,752,422$3,441,0003.10%
HIGHLINE CAPITAL MANAGEMENT, L.P. 1,235,869$1,545,0002.89%
New Leaf Venture Partners, L.L.C. 2,497,922$3,122,0001.85%
Frazier Life Sciences Management, L.P. 3,756,915$4,696,0000.36%
Orbimed Advisors 8,931,999$11,165,0000.21%
Newtyn Management, LLC 300,000$375,0000.08%
Deep Track Capital, LP 1,439,062$1,799,0000.08%
Rubric Capital Management LP 822,105$1,028,0000.05%
Oasis Management Co Ltd. 240,000$300,0000.05%
View complete list of PASSAGE BIO INC shareholders